PSBC yields 1000000.00% · ABBV yields 3.06%● Live data
📍 PSBC pulled ahead of the other in Year 1
Combined, PSBC + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PSBC + ABBV for your $10,000?
Pacific State Bancorp operates as the holding company for Pacific State Bank that provides commercial banking services to small and middle-market businesses and individuals in California. It offers various deposit products, including checking and savings accounts, individual retirement accounts, time deposits, and certificates of deposit. The company also provides loan products, such as commercial, construction, agricultural, and real estate loans, as well as personal credit lines. In addition, it offers the U.S. Savings bond services, domestic and foreign drafts, banking by appointment, automatic transfer of funds, business courier services, domestic letters of credit, a depository for MasterCard and Visa drafts, federal depository services, cash management assistance services, wire and telephone transfers, and courier services for non-cash deposits. Further, the company provides Visa and MasterCard cards; revolving lines of credit to consumers secured by deeds of trust on private residences; unsecured overdraft protection credit lines attached to checking accounts; and ATM cards and MasterMoney debit cards. The company was founded in 2002 and is based in Stockton, California with administrative office located in Stockton, California; and additional branches located in the communities of Angels Camp, Arnold, Groveland, Lodi, Modesto, Stockton, Tracy, and Hayward, California.
Full PSBC Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.